BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15034788)

  • 1. Primary central nervous system lymphoma in Japan 1995-1999: changes from the preceding 10 years.
    Shibamoto Y; Tsuchida E; Seki K; Oya N; Hasegawa M; Toda Y; Takemoto M; Sumi M; Hiratsuka J; Oguchi M; Hosono M; Yasuda S; Sougawa M; Kakutoh Y; Hayabuchi N
    J Cancer Res Clin Oncol; 2004 Jun; 130(6):351-6. PubMed ID: 15034788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
    Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
    Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
    Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
    van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
    Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.
    Shibamoto Y; Ogino H; Suzuki G; Takemoto M; Araki N; Isobe K; Tsuchida E; Nakamura K; Kenjo M; Suzuki K; Hosono M; Tokumaru S; Ishihara S; Kato E; Ii N; Hayabuchi N
    Neuro Oncol; 2008 Aug; 10(4):560-8. PubMed ID: 18559969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
    Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
    World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system lymphoma in Japan: a nationwide survey.
    Hayabuchi N; Shibamoto Y; Onizuka Y
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of primary central nervous system lymphoma treated by radiation and chemotherapy: retrospective analysis of twelve institutions in the Tokai District of Japan, 1995-1999.
    Kawamura T; Ishiguchi T; Shibamoto Y; Ogino H; Ishihara S; Yamada T; Katada K; Suzuki K; Suzuki H; Mimura M
    Radiat Med; 2006 Jan; 24(1):9-16. PubMed ID: 16715656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.
    Salvesen Haldorsen I; Aarseth JH; Hollender A; Larsen JL; Espeland A; Mella O
    Acta Oncol; 2004; 43(6):520-9. PubMed ID: 15370608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.
    Enblad G; Martinsson G; Baecklund E; Hesselager G; Sundström C; Amini RM; Hagberg H
    Acta Oncol; 2017 Apr; 56(4):599-607. PubMed ID: 28084866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma.
    Karmali R; Nabhan C; Petrich AM; Raizer J; Peace D; Lukas R; Gordon LI; Basu S; Chukkapalli V; Venugopal P
    Br J Haematol; 2017 Apr; 177(1):72-79. PubMed ID: 28211579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
    Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
    Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 14. The Cleveland Clinic experience with primary central nervous system lymphoma.
    Xie H; Ahluwalia MS; Peereboom DM
    Am J Clin Oncol; 2015 Apr; 38(2):140-6. PubMed ID: 23608829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
    Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.
    Grimm SA; McCannel CA; Omuro AM; Ferreri AJ; Blay JY; Neuwelt EA; Siegal T; Batchelor T; Jahnke K; Shenkier TN; Hall AJ; Graus F; Herrlinger U; Schiff D; Raizer J; Rubenstein J; Laperriere N; Thiel E; Doolittle N; Iwamoto FM; Abrey LE
    Neurology; 2008 Oct; 71(17):1355-60. PubMed ID: 18936428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
    Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
    Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of treatment in older adults with primary central nervous system lymphoma.
    Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
    Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.